IP Verse

Hgf competitive analysis

Explore patent oppositions filed by Hgf against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 9, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3752134	Methods And Compositions For Treating Vitiligo	CENTRE HOSPITALIER UNIVERSITAIRE DE NICE	Sep 3, 2025
EP3303401	Treatment Of Cancer By Manipulation Of Commensal Microflora	THE UNIVERSITY OF CHICAGO	Jul 16, 2025
EP3770258	Modulation Of Ube3A-Ats Expression	BAYLOR COLLEGE OF MEDICINE	Apr 16, 2025
EP4041186	An Anhydrous Pharmaceutical Composition For Maintenance Treatment Of Psoriasis	LEO PHARMA	Feb 24, 2025
EP2662094	Cylodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors	ONYX THERAPEUTICS	Jan 17, 2025
EP3184632	Hyperactive Piggybac Transposases	POSEIDA THERAPEUTICS	Jan 2, 2025
EP3628319	Methods Of Treating Hepatic Encephalopathy Using Rifaximin	SALIX PHARMACEUTICALS	Nov 4, 2024
EP2395968	Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A Patient	BOEHRINGER INGELHEIM	Oct 17, 2024
EP4037972	Gpu For The Provision Of Electrical Energy For Aircraft	DYNELL	Aug 22, 2024
EP3607936	Pharmaceutical Composition	MEXICHEM FLUOR DE CV	Aug 8, 2024

Explore the latest publications and patents granted to Hgf, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Hgf, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Hgf with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 9, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
HGF	74	-	-	-
AMGEN	8	137	8	11
BOEHRINGER INGELHEIM	3	130	2	1
NOVARTIS	6	417	-	21